Clinical Trial Update: A Pharmacokinetic Study of AMG 386 in Cancer Subjects With Normal and Impaired Renal Function [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetic study evaluating AMG 386 (trebananib) in cancer patients with normal and impaired renal function to assess how kidney function affects…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Kidney Disease

Drugs mentioned

• AMG 386 (trebananib) (trebananib)

Snippet

Sponsor: Amgen | Conditions: Advanced Solid Tumors, Kidney Disease | Phase 1 | Status: COMPLETED